Drug interactions between amiodarone and sofosbuvir
Interactions between your drugs
Applies to: amiodarone and sofosbuvir
Using amiodarone together with sofosbuvir can cause excessive slowing of your heart rate that can lead to serious or life-threatening cardiac complications. This is most likely to occur early on after you start treatment with these medications, especially within the first 48 hours. It may be alright for you to receive both medications; however, treatment should be initiated under close medical supervision. Your first dose of medication must be taken at your doctor's office or in a hospital where they can monitor your heart rate, and you will need to have your heart rate monitored every day for at least the first 2 weeks of treatment. Contact your doctor if you develop dizziness, lightheadedness, fainting, shortness of breath, confusion, weakness, excessive tiredness, chest pain, or heart palpitations at any time during treatment. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
Applies to: amiodarone
Amiodarone may be taken with or without food but should be taken at the same way each time. You should avoid consuming grapefruits and grapefruit juice while taking amiodarone. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor. Grapefruit can raise the levels of amiodarone in your body and lead to dangerous side effects. This can affect the rhythm of your heart. Call your doctor if you have symptoms of irregular heartbeat, chest tightness, blurred vision or nausea.
Therapeutic duplication warnings
No therapeutic duplications were found for your selected drugs.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.